| Share-Based Payment Arrangement [Text Block] |
NOTE 5 - STOCK-BASED COMPENSATION
On September 7, 2023, the Company adopted the ECB Bancorp, Inc. 2023 Equity Incentive Plan ("2023 Equity Plan”). The 2023 Equity Plan authorizes 1,248,133 shares of common stock for equity based compensation awards including restricted stock awards, restricted stock units and stock options, including incentive stock options.
The following table summarizes the Company's stock option activities for the periods indicated:
| | | Three months ended June 30, 2025 | | | Six months ended June 30, 2025 | |
| | | Outstanding and exercisable | | | Non-vested | | | Outstanding and exercisable | | | Non-vested | |
| | | | | | | Weighted-Average | | | | | | | Weighted-Average | | | | | | | Weighted-Average | | | | | | | Weighted-Average | |
| | | Shares | | | Exercise Price | | | Shares | | | Exercise Price | | | Shares | | | Exercise Price | | | Shares | | | Exercise Price | |
| Balance at beginning of period | | | 146,962 | | | $ | 10.45 | | | | 611,175 | | | $ | 10.50 | | | | 146,962 | | | $ | 10.45 | | | | 611,175 | | | $ | 10.50 | |
| Granted | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
| Vested | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
| Exercised | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
| Forfeited or expired | | | — | | | | — | | | | (23,328 | ) | | | 11.80 | | | | — | | | | — | | | | (23,328 | ) | | | 11.80 | |
| Balance at end of period | | | 146,962 | | | $ | 10.45 | | | | 587,847 | | | $ | 10.45 | | | | 146,962 | | | $ | 10.45 | | | | 587,847 | | | $ | 10.45 | |
| | | Three months ended June 30, 2024 | | | Six months ended June 30, 2024 | |
| | | Outstanding and exercisable | | | Non-vested | | | Outstanding and exercisable | | | Non-vested | |
| | | | | | | Weighted-Average | | | | | | | Weighted-Average | | | | | | | Weighted-Average | | | | | | | Weighted-Average | |
| | | Shares | | | Exercise Price | | | Shares | | | Exercise Price | | | Shares | | | Exercise Price | | | Shares | | | Exercise Price | |
| Balance at beginning of period | | | — | | | $ | — | | | | 763,969 | | | $ | 10.50 | | | | — | | | $ | — | | | | 763,969 | | | $ | 10.50 | |
| Granted | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
| Vested | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
| Exercised | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
| Forfeited or expired | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | | | | — | |
| Balance at end of period | | | — | | | $ | — | | | | 763,969 | | | $ | 10.50 | | | | — | | | $ | — | | | | 763,969 | | | $ | 10.50 | |
The restricted stock awards are measured based on grant-date fair value, which reflects the closing price of our stock on the date of grant. All of the restricted stock awards which have been granted to date vest over five years in equal portions beginning on the first anniversary date of the restricted stock award. The following table represents information regarding non-vested restricted stock award activities for the periods indicated:
| | | Three Months Ended | | | Six Months Ended | |
| | | June 30, 2025 | | | June 30, 2025 | |
| | | | | | | Weighted-Average | | | | | | | Weighted-Average | |
| | | | | | | Grant Date | | | | | | | Grant Date | |
| | | | | | | Fair Value | | | | | | | Fair Value | |
| | | Number of Shares | | | Per Share | | | Number of Shares | | | Per Share | |
| Balance at beginning of period | | | 245,766 | | | $ | 10.51 | | | | 245,766 | | | $ | 10.51 | |
| Granted | | | — | | | | — | | | | — | | | | — | |
| Vested | | | — | | | | — | | | | — | | | | — | |
| Forfeited | | | (9,331 | ) | | | 11.80 | | | | (9,331 | ) | | | 11.80 | |
| Balance at end of period | | | 236,435 | | | $ | 10.46 | | | | 236,435 | | | $ | 10.46 | |
| | | Three Months Ended | | | Six Months Ended | |
| | | June 30, 2024 | | | June 30, 2024 | |
| | | | | | | Weighted-Average | | | | | | | Weighted-Average | |
| | | | | | | Grant Date | | | | | | | Grant Date | |
| | | | | | | Fair Value | | | | | | | Fair Value | |
| | | Number of Shares | | | Per Share | | | Number of Shares | | | Per Share | |
| Balance at beginning of period | | | 305,957 | | | $ | 10.50 | | | | 305,957 | | | $ | 10.50 | |
| Granted | | | — | | | | — | | | | — | | | | — | |
| Vested | | | — | | | | — | | | | — | | | | — | |
| Forfeited | | | — | | | | — | | | | — | | | | — | |
| Balance at end of period | | | 305,957 | | | $ | 10.50 | | | | 305,957 | | | $ | 10.50 | |
The following table represents the compensation expense and income tax benefits recognized for stock options and restricted stock awards for the periods indicated:
| | | Three months ended | | | Three months ended | | | Six months ended | | | Six months ended | |
| | | June 30, 2025 | | | June 30, 2024 | | | June 30, 2025 | | | June 30, 2024 | |
| | | (in thousands) | | | (in thousands) | |
| Stock-based compensation expense | | | | | | | | | | | | | | | | |
| Stock options | | $ | 142 | | | $ | 165 | | | $ | 304 | | | $ | 329 | |
| Restricted stock awards | | | 139 | | | | 160 | | | | 298 | | | | 320 | |
| Total stock-based compensation expense | | $ | 281 | | | $ | 325 | | | $ | 602 | | | $ | 649 | |
| Related tax benefits recognized in earnings | | $ | 58 | | | $ | 71 | | | $ | 128 | | | $ | 140 | |
The following table sets forth the total compensation cost related to non-vested awards not yet recognized and the weighted average period (in years) over which it is expected to be recognized as of the periods indicated:
| | | June 30, 2025 | | | December 31, 2024 | |
| | | | | | | Weighted average | | | | | | | Weighted average | |
| | | Amount | | | period | | | Amount | | | period | |
| | | (Dollars in thousands) | |
| Stock options | | $ | 2,086 | | | | 3.31 | | | $ | 2,501 | | | | 3.80 | |
| Restricted stock awards | | | 2,041 | | | | 3.31 | | | | 2,449 | | | | 3.80 | |
| Total | | $ | 4,127 | | | | | | | $ | 4,950 | | | | | |
|